Immune Response Corp. Plans Offering: The San...
From Times Staff and Wire Reports
Immune Response Corp. Plans Offering: The San Diego biotechnology company co-founded by Jonas Salk, which is trying to develop an AIDS vaccine, has filed for permission to hold an 2.2-million-share initial public stock offering to raise as much as $19.8 million. Now in advanced clinical trials at several medical centers, the firm’s vaccine aims at stimulating patients’ immune response systems to prevent the disease from progressing to full-blown AIDS. The company had planned to go public last fall, but the offering was called off after the stock market soured.
